Application 019463

Type
NDA
Sponsor
VALEANT PHARMS INTL

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001TIMOPTIC IN OCUDOSETIMOLOL MALEATESOLUTION/DROPS;OPHTHALMICEQ 0.25% BASEYesYes
002TIMOPTIC IN OCUDOSETIMOLOL MALEATESOLUTION/DROPS;OPHTHALMICEQ 0.5% BASEYesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0187-1496Timoptic in OcudoseTimolol MaleateBausch Health Americas Inc.NDACurrent
0187-1496Timoptic in OcudoseTimolol MaleateValeant Pharmaceuticals North America LLCNDACurrent
0187-1496Timoptic in OcudoseTimolol MaleateBausch Health US LLCNDACurrent
0187-1496Timoptic in OcudoseTimolol MaleateBausch Health US LLCNDACurrent
0187-1496Timoptic in OcudoseTimolol MaleateBausch Health US LLCNDACurrent
0187-1498Timoptic in OcudoseTimolol MaleateBausch Health Americas Inc.NDACurrent
0187-1498Timoptic in OcudoseTimolol MaleateValeant Pharmaceuticals North America LLCNDACurrent
0187-1498Timoptic in OcudoseTimolol MaleateBausch Health US LLCNDACurrent
0187-1498Timoptic in OcudoseTimolol MaleateBausch Health US LLCNDACurrent
0187-1498Timoptic in OcudoseTimolol MaleateBausch Health US LLCNDACurrent
24208-496Timolol MaleateTimolol MaleateBAUSCH & LOMB INCORPORATEDNDA AUTHORIZED GENERICCurrent
24208-498Timoptic in OcudoseTimolol MaleateBausch & Lomb IncorporatedNDACurrent
24208-499Timoptic in OcudoseTimolol MaleateBausch & Lomb IncorporatedNDACurrent
25010-814TimopticTimolol MaleateAton Pharma, Inc.NDACurrent
25010-815TimopticTimolol MaleateAton Pharma, Inc.NDACurrent
82260-496Timolol MaleateTimolol MaleateBausch & Lomb Americas Inc.NDA AUTHORIZED GENERICCurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
47975SUPPL2017-04-12
47893SUPPL2017-04-07
17412SUPPL2011-10-03
33758SUPPL2011-09-30
1335SUPPL2006-06-08
33757SUPPL2006-06-06
20248SUPPL2006-05-08
33756SUPPL2003-12-29
1334SUPPL2003-12-24
20247SUPPL2003-09-11
33755SUPPL2003-04-15